Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 1.950
-0.100 (-4.88%)
Aug 14, 2026, 5:22 PM CET
Enzymatica AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 51.93 | 53.9 | 45.58 | 50.9 | 48.95 | 57.24 | |
Revenue Growth | 3.26% | 18.27% | -10.47% | 4.00% | -14.49% | -48.54% |
Cost of Revenue | 21.97 | 20.78 | 14.86 | 19.04 | 20.49 | 23.89 |
Gross Profit | 29.96 | 33.13 | 30.72 | 31.86 | 28.45 | 33.35 |
Selling, General & Admin | 62.85 | 69.67 | 68.02 | 67.79 | 71.5 | 55.42 |
Research & Development | 12.49 | 15.66 | 15.46 | 15.31 | 26.5 | 24.21 |
Other Operating Expenses | -0.72 | -0.84 | -0.71 | -3.17 | -1.33 | -1.04 |
Operating Expenses | 74.62 | 84.49 | 82.77 | 79.93 | 96.67 | 78.6 |
Operating Income | -44.67 | -51.37 | -52.05 | -48.06 | -68.22 | -45.25 |
Interest Expense | -0.05 | -0.07 | -1.72 | -2.09 | -1 | -0.89 |
Interest & Investment Income | 0.62 | 0.64 | 0.52 | 0.34 | 0.03 | 0 |
Currency Exchange Gain (Loss) | -1.04 | -1.04 | -0.08 | 0.09 | 0.43 | 0.43 |
Other Non Operating Income (Expenses) | 0 | 0 | -0 | 0 | 0 | - |
EBT Excluding Unusual Items | -45.13 | -51.84 | -53.34 | -49.72 | -68.75 | -45.7 |
Pretax Income | -45.13 | -51.84 | -53.34 | -49.72 | -68.75 | -45.7 |
Income Tax Expense | 0.72 | 0.05 | -0.16 | 0.01 | -0.09 | -0.31 |
Net Income | -45.85 | -51.89 | -53.18 | -49.73 | -68.66 | -45.39 |
Net Income to Common | -45.85 | -51.89 | -53.18 | -49.73 | -68.66 | -45.39 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 243 | 243 | 193 | 164 | 154 | 147 |
Shares Outstanding (Diluted) | 243 | 243 | 193 | 164 | 154 | 147 |
Shares Change | 6.03% | 25.94% | 17.34% | 6.45% | 5.24% | 2.66% |
EPS (Basic) | -0.19 | -0.21 | -0.28 | -0.30 | -0.44 | -0.31 |
EPS (Diluted) | -0.19 | -0.21 | -0.28 | -0.30 | -0.44 | -0.31 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -29.85 | -41.2 | -60.9 | -41.02 | -68.28 | -41.49 |
Free Cash Flow Per Share | -0.12 | -0.17 | -0.32 | -0.25 | -0.44 | -0.28 |
Gross Margin | 57.69% | 61.45% | 67.40% | 62.59% | 58.13% | 58.26% |
Operating Margin | -86.01% | -95.30% | -114.22% | -94.42% | -139.37% | -79.04% |
Profit Margin | -88.30% | -96.27% | -116.68% | -97.69% | -140.26% | -79.30% |
Free Cash Flow Margin | -57.48% | -76.44% | -133.63% | -80.58% | -139.50% | -72.49% |
EBITDA | -42.27 | -48.83 | -49.23 | -44.96 | -65.08 | -43.11 |
EBITDA Margin | -81.39% | -90.58% | -108.01% | -88.32% | -132.95% | -75.30% |
D&A For EBITDA | 2.4 | 2.54 | 2.83 | 3.11 | 3.14 | 2.14 |
EBIT | -44.67 | -51.37 | -52.05 | -48.06 | -68.22 | -45.25 |
EBIT Margin | -86.01% | -95.30% | -114.22% | -94.42% | -139.37% | -79.04% |